Visit us at AMP Europe 2018 and explore how QIAGEN Clinical Insight (QCI) Interpret can standardize your variant interpretation and reporting
QCI Interpret for somatic cancer is an integrated clinical decision support solution designed specifically for routine somatic cancer testing laboratories assessing next-generation sequencing (NGS) data. With QCI you can interpret and report NGS variants in the context of over 10 million relevant biomedical findings from the QIAGEN Knowledge Base, leveraging the experience of over 16+ years in manual curation. QCI allows you to minimize complexity, time and cost associated with determining clinical significance and action-ability of NGS variants.
See how advanced bioinformatics tools such as QCI-Interpret help to analyze and interpret vast amounts of genomic data to generate valuable insights.